Edesa Biotech, Inc.
EDSA
$2.46
$0.0251.03%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.87% | 14.55% | 3.65% | 44.07% | 15.96% |
| Total Depreciation and Amortization | -49.81% | -46.04% | -4.22% | -3.91% | -38.07% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 62.01% | -50.56% | -55.97% | -81.84% | 1.20% |
| Change in Net Operating Assets | -123.74% | -4,350.00% | -156.94% | 53.94% | 5,759.13% |
| Cash from Operations | -98.58% | -43.55% | -7.87% | 34.13% | 52.55% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | 2,391.08% | 98.86% | -100.00% | -83.40% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -1,168.12% | -910.53% | 55.96% | 64.97% |
| Cash from Financing | -100.00% | 6,878.22% | 577.63% | -107.61% | -85.70% |
| Foreign Exchange rate Adjustments | 2,097.59% | -186.29% | -491.67% | 87.31% | -116.63% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -102.32% | 940.01% | 148.12% | 8.41% | 25.18% |